S. Sundar
Public Health, Environmental and Occupational Health · 2000–2007
A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Public Health, Environmental and Occupational Health — 10 citations into it; #1,572 of 2,368 by trust here, #493 by citations
- Epidemiology — 7 citations into it; #1,348 of 2,148 by trust here, #1,155 by citations
Whom S. Sundar trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts S. Sundar overall
Papers from S. Sundar's perspective
Ordered by how strongly the researchers S. Sundar trusts endorse each paper. Same corpus, a different order for every researcher.
- Leishmaniasis and poverty. (Trends in Parasitology)
- Injectable paromomycin for Visceral leishmaniasis in India.
- Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. (Clinical Infectious Diseases)
- Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis.
- Leishmaniasis: current situation and new perspectives. (Comparative Immunology, Microbiology & Infectious Diseases)
- The leishmaniases as emerging and reemerging zoonoses. (International Journal of Parasitology)
- Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and Malaria (PLoS Medicine)
- The phosphoinositide 3-kinase pathway. (Science)
- Multidrug resistance in cancer: role of ATP–dependent transporters (Nature Reviews. Cancer)
- The biochemistry of apoptosis (Nature)
Their papers
- Injectable paromomycin for Visceral leishmaniasis in India. (2007) — 437 citations
- Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? (2007) — 1,617 citations
- Drug Resistance in Leishmaniasis (2006) — 1,823 citations
- Laboratory Diagnosis of Visceral Leishmaniasis (2002) — 603 citations
- Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. (2002) — 787 citations
- Oral miltefosine for Indian visceral leishmaniasis. (2002) — 766 citations
- Drug resistance in Indian visceral leishmaniasis (2001) — 611 citations
- Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. (2000) — 677 citations